SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies

Clinical trial NCT01744236 · COMPLETED

Trial details

NCT number: NCT01744236
Sponsor: Amsterdam UMC, location VUmc
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2013-04-01
Primary completion: 2015-08-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.